Report cover image

United States Proton Therapy Market, Size, Forecast 2022-2027, Industry Trends, Impact of COVID-19, Growth, Opportunity Company Analysis

Publisher Renub Research
Published Jan 01, 2022
Length 200 Pages
SKU # RNBR16906322

Description

United States Proton Therapy Market, Size, Forecast 2022-2027, Industry Trends, Impact of COVID-19, Growth, Opportunity Company Analysis

The United States Proton Therapy Market is expected to reach US$ 1.8 Billion by 2027. Proton therapy is an excellent treatment alternative for numerous patients, especially those with tumours close to vital organs. Besides, for children, those most vulnerable and susceptive to the damage of conventional radiation therapy, proton therapy offers less radiation exposure while demoting side effects. In addition, proton therapy is a high-tech option for X-ray radiation. With online image guidance, a scanning beam of proton radiation advises greater precision to destroy carcinogenic cells, sparing adjacent healthy tissue with more infrequent side effects.

COVID-19 Impact on United States Proton Therapy Industry:

Despite the outbreak of COVID-19 worldwide, the proton therapy market has increased at a constant speed. It was only stopped for a brief period in the initial months of the pandemic outbreak but later resumed to take care of the cancer patients and radiation therapies patients in the United States; many procedures have been finalized to help the patients with therapies. Such as, many implementations and algorithms have been carried out to safeguard the radiation patients from COVID-19.

United States Proton Therapy Market will grow with a CAGR of 8.5% during the period 2021-2027

The rise of the proton therapy industry in the United States is mainly driven by rising healthcare expenditure, expanding preference for advanced therapies by healthcare practitioners, increasing confirmation and increasing cancer pervasiveness. Another outstanding growth driver is the faster uptake and access along with premium pricing. As per our analysis, United States Proton Therapy Market Size was US$ 1.1 Billion post-pandemic recoveries in 2021.

Cancer Types - Market Segmentation:

Based on Cancer Types, the proton therapy market of the United States is further segmented into Central Nervous System Tumors, Intraocular Melanomas Cancer, Pituitary Neoplasms Cancer, Base of Skull / Axial Skeleton Cancer, Head and Neck Cancer, Lung Cancer, Retroperitoneal Sarcoma Cancer, Pediatric Cancer (Up to Age 18), Gastrointestinal Tract Cancer, Urinary Tract Cancer, Female Pelvic Organs Cancer, Prostate Cancer, and Breast Cancer.

Besides, proton therapy applications are more inclined towards Gastrointestinal Tract Cancer and lung cancer due to references by healthcare specialists. Moreover, proton therapy is also recognized to be comparatively safer in the case of paediatric patients who have cancer. These applications are anticipated to drive the revenue for the proton therapy industry over the forecast period.

Competitive Landscape:

Companies in the United States Proton Therapy Market are trying to create their mark by adopting new technologies at an accelerated rate. The company has also tried to enrich their product catalogues through product developments. Also, companies have acquired small companies to resolve the potential resource gap that prevailed in their technologies and products. The major players of the United States Proton Therapy Market studied in our report are IBA Proton Therapy, Varian Medical Systems, and Elekta.

Renub Research latest report “Proton Therapy Patients Number & Market, Global Forecast By Cancer Types (Central Nervous System Tumors, Intraocular Melanomas Cancer, Pituitary Neoplasms Cancer, Base of Skull / Axial Skeleton Cancer, Head and Neck Cancer, Lung Cancer, Retroperitoneal Sarcoma Cancer, Pediatric Cancer (Up to Age 18), Gastrointestinal Tract Cancer, Urinary Tract Cancer, Female Pelvic Organs Cancer, Prostate Cancer, Breast Cancer and Others), Company (IBA Proton Therapy, Varian Medical Systems, Elekta)” provides a detailed analysis of United States Proton Therapy Industry.

Cancer Types – United States Proton Therapy Market has been covered from 14 viewpoints:

1. Central Nervous System Tumors
2. Intraocular Melanomas Cancer
3. Pituitary Neoplasms Cancer
4. Base of Skull / Axial Skeleton Cancer
5. Head and Neck Cancer
6. Lung Cancer
7. Retroperitoneal Sarcoma Cancer
8. Pediatric Cancer Cases (Up to Age 18)
9. Gastrointestinal Tract Cancer
10. Urinary Tract Cancer
11. By Female Pelvic Organs Cancer
12. Prostate Cancer
13. Breast Cancer
14. Other Cancer

Cancer Types – Patients Number in United States Proton Therapy Market has been covered from 14 viewpoints:

1. Central Nervous System Tumors
2. Intraocular Melanomas Cancer
3. Pituitary Neoplasms Cancer
4. Base of Skull / Axial Skeleton Cancer
5. Head and Neck Cancer
6. Lung Cancer
7. Retroperitoneal Sarcoma Cancer
8. Pediatric Cancer (Up to Age 18)
9. Gastrointestinal Tract Cancer
10. Urinary Tract Cancer
11. Female Pelvic Organs Cancer
12. Prostate Cancer
13. Breast Cancer
14. Other Cancer

All companies have been covered from 3 viewpoints:

• Overview
• Recent Developments
• Sales Analysis

Companies Covered:

1. IBA Proton Therapy
2. Varian Medical Systems
3. Elekta

Table of Contents

200 Pages
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Market (Actual & Potential) – United States Proton Therapy Market
5.1 Actual Proton Therapy Market
5.2 Potential Proton Therapy Market
6. Number of Patients – United States Proton Therapy
6.1 Actual Numbers
6.2 Potential Numbers
7. Cancer Types – United States Proton Therapy Market
7.1 Central Nervous System Tumors
7.2 Intraocular Melanomas Cancer
7.3 Pituitary Neoplasms Cancer
7.4 Base of Skull / Axial Skeleton Cancer
7.5 Head and Neck Cancer
7.6 Lung Cancer
7.7 Retroperitoneal Sarcoma Cancer
7.8 Pediatric Cancer Cases (Up to Age 18)
7.9 Gastrointestinal Tract Cancer
7.10 Urinary Tract Cancer
7.11 By Female Pelvic Organs Cancer
7.12 Prostate Cancer
7.13 Breast Cancer
7.14 Other Cancer
8. Cancer Types – United States Proton Therapy Patients Numbers
8.1 Central Nervous System Tumors
8.2 Intraocular Melanomas Cancer
8.3 Pituitary Neoplasms Cancer
8.4 Base of Skull / Axial Skeleton Cancer
8.5 Head and Neck Cancer
8.6 Lung Cancer
8.7 Retroperitoneal Sarcoma Cancer
8.8 Pediatric Cancer (Up to Age 18)
8.9 Gastrointestinal Tract Cancer
8.10 Urinary Tract Cancer
8.11 Female Pelvic Organs Cancer
8.12 Prostate Cancer
8.13 Breast Cancer
8.14 Other Cancer
9. United States – List of Proton Therapy Centers
9.1 Operating Proton Therapy Centers
9.2 Under-Construction Therapy Centers
9.3 Planning Proton Therapy Centers
10. Proton Therapy – Reimbursement Policies
10.1 Proton Therapy Reimbursement Policies for Patients
10.2 Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers
11. Components of a Standard Proton Therapy Center
11.1 Proton Accelerator
11.1.1 Synchrotrons (example: LLUMC at Loma Linda)
11.1.2 Cyclotrons (example: MGH Boston)
11.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
11.1.4 Linacs (Rome)
11.1.5 H-minus Synchrotrons
11.1.6 Separated Sector Cyclotrons
11.1.7 Super-conducting Cyclotrons
11.1.8 Fast Cycling Synchrotron
11.2 Beam Transport System
11.3 Beam Delivery System
11.3.1 The Passive Scattering Technique
11.3.2 Beam Scanning
11.4 Nozzle
11.4.1 Single Scattering
11.4.2 Double Scattering
11.4.3 Uniform Scanning Nozzle
11.4.4 Pencil Scanning Nozzle
11.5 Treatment Planning System
11.6 Image Viewers
11.7 Patient Positioning System (PPS)
11.8 Human Resource
12. Porters Five Forces
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13. Company Analysis
13.1 IBA Proton Therapy
13.1.1 Overview
13.1.2 Recent Developments
13.1.3 Sales Analysis
13.2 Varian Medical Systems
13.2.1 Overview
13.2.2 Recent Developments
13.2.3 Sales Analysis
13.3 Elekta
13.3.1 Overview
13.3.2 Recent Developments
13.3.3 Sales Analysis
List Of Figures:
Figure-01: United States – Actual Proton Therapy Market (Million US$), 2016 – 2021
Figure-02: United States – Forecast for Actual Proton Therapy Market (Million US$), 2022 – 2027
Figure-03: United States – Potential Proton Therapy Market (Million US$), 2016 – 2021
Figure-04: United States – Forecast for Potential Proton Therapy Market (Million US$), 2022 – 2027
Figure-05: United States – Actual Numbers Patients Volume (Number), 2016 – 2021
Figure-06: United States – Forecast for Actual Numbers Patients Volume (Number), 2022 – 2027
Figure-07: United States – Potential Numbers Patients Volume (Number), 2016 – 2021
Figure-08: United States – Forecast for Potential Numbers Patients Volume (Number), 2022 – 2027
Figure-09: Central Nervous System Tumors Patients Volume (Number), 2016 – 2021
Figure-10: Forecast for – Central Nervous System Tumors Patients Volume (Number), 2022 – 2027
Figure-11: Intraocular Melanomas Cancer Patients Volume (Number), 2016 – 2021
Figure-12: Forecast for – Intraocular Melanomas Cancer Patients Volume (Number), 2022 – 2027
Figure-13: Pituitary Neoplasms Cancer Patients Volume (Number), 2016 – 2021
Figure-14: Forecast for – Pituitary Neoplasms Cancer Patients Volume (Number), 2022 – 2027
Figure-15: Base of Skull / Axial Skeleton Cancer Patients Volume (Number), 2016 – 2021
Figure-16: Forecast for – Base of Skull / Axial Skeleton Cancer Patients Volume (Number), 2022 – 2027
Figure-17: Head and Neck Cancer Patients Volume (Number), 2016 – 2021
Figure-18: Forecast for – Head and Neck Cancer Patients Volume (Number), 2022 – 2027
Figure-19: Lung Cancer Patients Volume (Number), 2016 – 2021
Figure-20: Forecast for – Lung Cancer Patients Volume (Number), 2022 – 2027
Figure-21: Retroperitoneal Sarcoma Cancer Patients Volume (Number), 2016 – 2021
Figure-22: Forecast for – Retroperitoneal Sarcoma Cancer Patients Volume (Number), 2022 – 2027
Figure-23: Pediatric Cancer Cases (Up to Age 18) Patients Volume (Number), 2016 – 2021
Figure-24: Forecast for – Pediatric Cancer Cases (Up to Age 18) Patients Volume (Number), 2022 – 2027
Figure-25: Gastrointestinal Tract Cancer Patients Volume (Number), 2016 – 2021
Figure-26: Forecast for – Gastrointestinal Tract Cancer Patients Volume (Number), 2022 – 2027
Figure-27: Urinary Tract Cancer Patients Volume (Number), 2016 – 2021
Figure-28: Forecast for – Urinary Tract Cancer Patients Volume (Number), 2022 – 2027
Figure-29: By Female Pelvic Organs Cancer Patients Volume (Number), 2016 – 2021
Figure-30: Forecast for – By Female Pelvic Organs Cancer Patients Volume (Number), 2022 – 2027
Figure-31: Prostate Cancer Patients Volume (Number), 2016 – 2021
Figure-32: Forecast for – Prostate Cancer Patients Volume (Number), 2022 – 2027
Figure-33: Breast Cancer Patients Volume (Number), 2016 – 2021
Figure-34: Forecast for – Breast Cancer Patients Volume (Number), 2022 – 2027
Figure-35: Other Cancer Patients Volume (Number), 2016 – 2021
Figure-36: Forecast for – Other Cancer Patients Volume (Number), 2022 – 2027
Figure-37: Central Nervous System Tumors Market (Million US$), 2016 – 2021
Figure-38: Forecast for – Central Nervous System Tumors Market (Million US$), 2022 – 2027
Figure-39: Intraocular Melanomas Cancer Market (Million US$), 2016 – 2021
Figure-40: Forecast for – Intraocular Melanomas Cancer Market (Million US$), 2022 – 2027
Figure-41: Pituitary Neoplasms Cancer Market (Million US$), 2016 – 2021
Figure-42: Forecast for – Pituitary Neoplasms Cancer Market (Million US$), 2022 – 2027
Figure-43: Base of Skull / Axial Skeleton Cancer Market (Million US$), 2016 – 2021
Figure-44: Forecast for – Base of Skull / Axial Skeleton Cancer Market (Million US$), 2022 – 2027
Figure-45: Head and Neck Cancer Market (Million US$), 2016 – 2021
Figure-46: Forecast for – Head and Neck Cancer Market (Million US$), 2022 – 2027
Figure-47: Lung Cancer Market (Million US$), 2016 – 2021
Figure-48: Forecast for – Lung Cancer Market (Million US$), 2022 – 2027
Figure-49: Retroperitoneal Sarcoma Cancer Market (Million US$), 2016 – 2021
Figure-50: Forecast for – Retroperitoneal Sarcoma Cancer Market (Million US$), 2022 – 2027
Figure-51: Pediatric Cancer (Up to Age 18) Market (Million US$), 2016 – 2021
Figure-52: Forecast for – Pediatric Cancer (Up to Age 18) Market (Million US$), 2022 – 2027
Figure-53: Gastrointestinal Tract Cancer Market (Million US$), 2016 – 2021
Figure-54: Forecast for – Gastrointestinal Tract Cancer Market (Million US$), 2022 – 2027
Figure-55: Urinary Tract Cancer Market (Million US$), 2016 – 2021
Figure-56: Forecast for – Urinary Tract Cancer Market (Million US$), 2022 – 2027
Figure-57: Female Pelvic Organs Cancer Market (Million US$), 2016 – 2021
Figure-58: Forecast for – Female Pelvic Organs Cancer Market (Million US$), 2022 – 2027
Figure-59: Prostate Cancer Market (Million US$), 2016 – 2021
Figure-60: Forecast for – Prostate Cancer Market (Million US$), 2022 – 2027
Figure-61: Breast Cancer Market (Million US$), 2016 – 2021
Figure-62: Forecast for – Breast Cancer Market (Million US$), 2022 – 2027
Figure-63: Other Cancer Market (Million US$), 2016 – 2021
Figure-64: Forecast for – Other Cancer Market (Million US$), 2022 – 2027
Figure-65: IBA Proton Therapy – Global Revenue (Million US$), 2016 – 2021
Figure-66: IBA Proton Therapy – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-67: Varian Medical Systems – Global Revenue (Million US$), 2016 – 2021
Figure-68: Varian Medical Systems – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-69: Elekta – Global Revenue (Million US$), 2016 – 2021
Figure-70: Elekta – Forecast for Global Revenue (Million US$), 2022 – 2027
List Of Tables:
Table-01: Operating Proton Therapy Centers
Table-02: Under-Construction Therapy Centers
Table-03: Planning Proton Therapy Centers

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us